Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.94 USD | +1.12% |
|
+0.53% | -18.16% |
01:37pm | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.16% | 84.08B | |
+47.49% | 765B | |
-6.81% | 354B | |
+19.37% | 331B | |
+8.80% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+4.53% | 164B | |
-2.68% | 162B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb Company to $37 From $40